100. Round, J. L. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota / J. L. Round, S. K. Mazmanian // Proc. Natl. Acad. Sc.i USA. 2010; 107: 12204–9.
101. O’Mahony, C. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-jB activation / C. O’Mahony, P. Scully, D. O’Mahony et al. // PLoS. Pathog. 2008; 4:e1000112.
102. Atarashi, K. Induction of colonic regulatory T cells by ind igenousClostridiumspecies / K. Atarashi, T. Tanoue, T. Shima et al. // Science. 2011;331:337–41.
103. Ivanov, I. I. Induction of intestinal Th17 cells by segmented filamentous bacteria / I. I. Ivanov, K. Atarashi, N. Manel et al. // Cell. 2009; 139:485–98.
104. Kaslowski, K. M. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 / K. M. Kaslowski, A. T. Vieira, A. Ng et al. // Nature. 2009;461:1282–6.
105. Falkow, S. What is a pathogen? / S. Falkow // ASM News. 1997; 63:359–65.
106. Stecher, B. The role of microbiota in infectious disease / B. Stecher, W. D. Hardt // Trends Microbiol. 2008;16:107–14.
107. Coombes, B. K. Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses / B. K. Coombes, Y. Valdez, B. B. Finlay // Cur. Biol. 2004;14:R856–67.
108. Lupp, C. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae / C. Lupp, M. L. Robertson, M. E. Wickham et al. // Cell Host Microbe. 2007; 2:119–29.
109. Stecher, B. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota / B. Stecher, R. Robbiani, A. W. Walker et al. // PLoS. Biol. 2007; 5:2177–89.
110. Iwasaki, A. Toll-like receptor control of the adaptive immune responses / A. Iwasaki, R. Medzhitov // Nat. Immunol. 2004;5:987–95.
111. Kawai, T. The roles of TLRs, RLRs and NLRs in pathogen recognition / T. Kawai, S. Akira // Int. Immunol. 2009;21:317–37.
112. Barthel, M. Pretreatment of mice with streptomycin provides a Salmonella entericaserovar Typhimurium colitis model that allows analysis of both pathogen and host / M. Barthel, S. Hapfelmeier, L. Quintanilla-Martinez et al. // Infect. Immun. 2003;71:2839–58.
113. Higgins, L. M. Role of bacterial intimin in colonic hyperplasia and inflammation / L. M. Higgins, G. Frankel, I. Connerton et al. // Science. 1999;285:588–91.
114. Geddes, K. Identification of an innate T helper type 17 response to intestinal bacterial pathogens / K. Geddes, S. J. Rubino, J. G. Magalhaes et al. // Nat. Med. 2011;17:837–44.
115. Lee, S. J. Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development / S. J. Lee, J. B. McLachlan, J. R. Kurtz et al. // PLoS. Pathog. 2012;8:e1002499.
116. Broz, P. Molecular mechanisms of inflammasome activation during microbial infections / P. Broz, D. M. Monack // Immunol. Rev. 2011;243:174–90.
117. Finlay, B. B. Salmonellainteractions with host cells: in vitro to in vivo // Philos. Trans. R Soc. Lond. B Biol. Sci. 2000;355:623–31.
118. Raffatellu, M. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine / M. Raffatellu, M. D. George, Y. Akiyama et al. // Cell Host. Microbe. 2009;5:476–86.
119. Stelter, C. Salmonellainduced mucosal lectin RegIIIbkills competing gut microbiota / C. Stelter, R. Kappeli, C. Konig // PLoS ONE. 2011;6: e20749.
120. Liu, J. Z. Zinc sequestration by the neutrophil protein calprotectin enhances salmonella growth in the inflamed gut / J. Z. Liu, S. Jellbauer, A. PoeJet al. // Cell Host. Microbe. 2012;11:227–39.
121. Thiennimitr, P. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota / P. Thiennimitr, S. E. Winter, M. G. Winter et al. // Proc. Nat.l Acad. Sc.i USA. 2011; 108:17480–5.
122. Winter, S. E. Gut inflammation provides a respiratory electron acceptor forSalmonella / S. E. Winter, P. Thiennimitr, M. G. Winter et al. // Nature. 2010;467:426–9.
123. Lawley, T. D. Host transmission of Salmonella entericaserovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota / T. D. Lawley, D. M. Bouley, Y. E. Hoy et al. // Infect. Immun. 2008;76:403–16.
124. Wickham, M. E. Virulence is positively selected by transmission success between mammalian hosts / M. E. Wickham, N. F. Brown, E. C. Boyle et al. // Curr. Biol. 2007;17:783–8.
125. Dethlefsen, L. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation / L. Dethlefsen, D. A. Relman, // Proc. Natl. Acad. Sci. USA. 2011;108 (Suppl. 1):4554–61.
126. Jernberg, C. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota / C. Jernberg, S. Lofmark, C. Edlund, J. K. Jansson / ISME J. 2007;1:56–66.
127. Blaser, M. J. What are the consequences of the disappearing human microbiota? / M. J. Blaser, S. Falkow // Nat. Rev. Microbiol. 2009;7:887–94.